Kintara Therapeutics Inc (NASDAQ: KTRA) is -47.17% lower on its value in year-to-date trading and has touched a low of $0.09 and a high of $5.98 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The KTRA stock was last observed hovering at around $0.09 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.09, the stock is -13.47% and -29.09% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.51 million and changing -5.19% at the moment leaves the stock -96.08% off its SMA200. KTRA registered -97.60% loss for a year compared to 6-month loss of -97.97%. The firm has a 200-day simple moving average (SMA200) of -$1.24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -21.68% gain in the last 1 month and extending the period to 3 months gives it a -67.89%, and is -10.93% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.07% over the week and 12.74% over the month.
Kintara Therapeutics Inc (KTRA) has around 17 employees, a market worth around $3.50M and $0.00M in sales. Distance from 52-week low is 4.07% and -98.50% from its 52-week high.
Kintara Therapeutics Inc quarterly earnings per share for the current quarter are estimated at $0.The EPS is expected to grow by 73.35% this year.
Kintara Therapeutics Inc (KTRA) Top Institutional Holders
9 institutions hold shares in Kintara Therapeutics Inc (KTRA), with institutional investors hold 0.62% of the company’s shares. The shares outstanding are 39.04M, and float is at 38.16M with Short Float at 1.08%. Institutions hold 0.62% of the Float.
The top institutional shareholder in the company is Geode Capital Management, LLC with over 14036.0 shares valued at $56565.0. The investor’s holdings represent 0.80% of the KTRA Shares outstanding. As of Jun 29, 2023, the second largest holder is State Street Corporation with 10721.0 shares valued at $43205.0 to account for 0.61% of the shares outstanding. The other top investors are Acadian Asset Management. LLC which holds 6480.0 shares representing 0.37% and valued at over $26114.0, while Tower Research Capital LLC (TRC) holds 0.27% of the shares totaling 4777.0 with a market value of $19251.0.
